Bayer folate campaign to star TV's Minnillo

Share this article:
Bayer HealthCare Pharmaceuticals, maker of the folate-enhanced contraceptives Safyral and Beyaz, has recruited TV personality Vanessa Minnillo to front an unbranded campaign promoting the use of daily folate supplements to women.

The Girlfriends for Folate campaign, for which the company has partnered with the March of Dimes and women's website DailyCandy.com, features a Facebook page and a competition inviting women to register with the site as a “GFF.” Bayer will donate $1 to the March of Dimes for every registration, and the winning region will host a celebrity walk, including Minnillo, the weekend of April 30. Registrants can also pitch in on fundraising, and the company will fly out the top fundraiser to walk with Minnillo.

Bayer won approval for two oral contraceptives last year – Safyral and Beyaz – that are similar to its Yasmin and Yaz, plus folate and a B vitamin. The contraceptives are indicated for boosting folate, thereby reducing the risk of serious birth defects, known as neural tube defects, in a pregnancy conceived while taking the product or shortly thereafter. In announcing Beyaz's approval, Bayer quoted Dr. Anita Nelson, professor of obstetrics and gynecology at the Harbor-UCLA Medical Center, Torrance, California as saying: “Combining an oral contraceptive with folate is important, because women may become pregnant during OC use or shortly after discontinuation, possibly before seeking preconception counseling from their healthcare provider. For women who want to use an oral contraceptive, Beyaz offers a new option for women to receive daily folate supplementation.”
Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.